FRA Rolls Out 1st Phase of Strategic Refocus With Appointment of Four Bioscience Leaders to Board

The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors.
 
 
Spread the Word
Listed Under

Tags:
* Bioscience
* Colorado
* Economic Development
* Biotech
* Medical Devices

Industrys:
* Biotech
* Business
* Medical

Location:
* Aurora - Colorado - US

Nov. 15, 2011 - PRLog -- Aurora, CO, November 15, 2011 - In a strategic effort to refocus and strengthen its organization, the Fitzsimons Redevelopment Authority (FRA) has completed a regimen of planning to make adjustments in the direction, roles, responsibilities and allocation of resources going forward. The announcement is made by Denise Brown, FRA Interim Executive Director, who says, "Our first tactic in refocus involves augmenting our board of directors with four of the area's most well-known and successful leaders in the bioscience industry."

Joining the FRA Board are Donald M. Elliman, Jr., Executive Director of the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology and current Director and former Chair of the Children's Hospital Colorado Board of Directors; William Freytag, PhD, former Chairman and CEO of Myogen, Inc.; James C. T. Linfield, Partner-in-Charge of the Colorado office of Cooley LLP;  and David Perez, President and Chief Executive Officer of CaridianBCT, becoming TerumoBCT.

Brown continues, "We're very pleased to welcome our new board members. These leaders are actively involved the bioscience community - locally, nationally and internationally - and maintain those critical relationships with entrepreneurs, companies and research groups required to guide the FRA through its next phase of growth. This is the first time the FRA has had bioscience executives on its board."

Other FRA Board members include: Bruce Benson, President, University of Colorado; Bruce Schroffel, President, University of Colorado Hospital; John Shaw, Principal, McWhinney; Lilly Marks, Vice President for Health Affairs and Executive Vice Chancellor of the Anschutz Medical Campus; Dwight Rider, Principal, Freund Investments; and Councilwoman Melissa Miller from Aurora who will be joined by two other elected officials to be named by the Aurora City Council.

About Fitzsimons Redevelopment Authority

The FRA directs the commercial developments in the Fitzsimons Life Science District, along with its partner, Forest City Science + Technology Group. Visit: http://www.fitzscience.com.

Contacts:

Vicki Jenings, CPM, Director of Business Relations, Fitzsimons Redevelopment Authority - http://www.fitzscience.com - 720-859-4108 - vjenings@colobio.com

Maggie Chamberlin Holben, APR, Principal - Absolutely Public Relations - http://www.absolutelypr.com - 303-984-9801 and 303-669-3558 (cell), maggie@absolutelypr.com
End
Source:Fitzsimons Redevelopment Corporatioin
Email:***@absolutelypr.com Email Verified
Phone:303-984-9801
Zip:80045
Tags:Bioscience, Colorado, Economic Development, Biotech, Medical Devices
Industry:Biotech, Business, Medical
Location:Aurora - Colorado - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Absolutely Public Relations News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share